ArticleChemistry & biodiversity2026
In Vitro Anti-Inflammatory Activity of Sour Cherry (Prunus cerasus L.) Seed Oil and Computational Safety Profiling.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
This study aimed to evaluate the in vitro anti-inflammatory activity of sour cherry seed oils, including samples obtained by Soxhlet extraction and maceration, as well as ten commercial samples. The results demonstrated that the 15-lipoxygenase inhibitory activity of the oil samples ranged from 6% to 80%. Regarding cyclooxygenase (COX) inhibition, while most samples showed negligible activity, the oil produced by Soxhlet extraction inhibited COX-1 and COX-2 by 38% and 32%, respectively. Similarly, the oil obtained via maceration showed inhibition rates of 25% and 23% for COX-1 and COX-2, respectively. In the trypsin inhibition assay, the Soxhlet-extracted and macerated oils exhibited 42% and 25% inhibition, respectively. Two market-supplied samples also showed considerable trypsin inhibitory activity, at 39% and 35%. In contrast, none of the sour cherry seed oil samples had a significant effect on chymotrypsin. Gas chromatography with flame ionization detection analysis revealed that linoleic acid, oleic acid, and palmitic acid were the major fatty acid components in all oil samples. Additionally, in silico ADMET profiling and molecular docking studies of the major fatty acids revealed favorable predicted safety profiles and strong binding affinities against the target enzymes, which, alongside the observed in vitro inhibitions, support its potential for further development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.